BLOGS

Achieving and maintaining constant audit readiness is a critical operational mandate for life sciences, manufacturing, and highly regulated industries—especially given the rise of unannounced FDA inspections. For two consecutive years, the State of Validation Report (State of Validation 2026) has ranked audit readiness as the #1 industry concern. Internal teams are frequently consumed by daily production demands or lose their objectivity over time—a phenomenon known as "opera

Do you see hair in this injectable solution? Injectable solutions are critical in modern medicine, delivering life-saving drugs directly into the body. Despite advances in pharmaceutical technology, the presence of particulate matter in these solutions remains a significant concern. Particulate contamination can compromise patient safety, affect drug efficacy, and lead to serious health complications. This issue has persisted for decades, prompting ongoing research and regu

It depends on whom you work for...Two important highlights: 1. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize - On April 01, 2026, FDA clarifies policies for compounders. The FDA stated that a compounded drug product is considered essentially a copy of a commercially available drug product if · The compounded drug product contains the same APIs as two or more commercially available drug product